ISSN: 1948-5964
+44 1300 500008
Bzikha Reda*, Bouhmou Ayoub, Bzikha Ilham and Bouchnafati Sanaa
Drugs that are efficacious against SARS-CoV-2 have yet to be established. Remdesivir and Lopinavir/ritonavir have garnered considerable attention for their potential to treat coronavirus disease 2019 (COVID-19). Remdesivir not only in vivo but also in vitro testing shows the inhibition of human coronavirus replication, including SARS-CoV as well as Lopinavir/ritonavir that shows promising antiviral drug against SARS-CoV-2.
Published Date: 2020-11-14; Received Date: 2020-10-24